ACM
FCSC

Akanthos Capital Management’s Fibrocell Science Inc. FCSC Stock Holding History

Akanthos Capital Management’s Portfolio FCSC Stock Details FCSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-3,767
Closed -$257K – 20
2015
Q4 		$257K Buy
3,767
+434
+13% +$31.2K 0.53% 15
2015
Q3 		$192K Buy
+3,333
New +$295K 0.29% 18
2013
Q3 		– Sell
-14,000
Closed -$1.28M – 32
2013
Q2 		$1.28M Buy
+14,000
New +$1.16M 3.5% 8

Other funds holding FCSC

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Akanthos Capital Management's FCSC Position: Q1 2016 in Review

Akanthos Capital Management sold out of Fibrocell Science Inc. (FCSC) in Q1 2016, closing a stake of 3,767 shares — an estimated $257K sold.

Akanthos Capital Management first reported a position in FCSC in Q2 2013 and held it in 3 quarters. The position peaked at $1.28M in Q2 2013. 52 funds tracked by Wall St. Rank hold FCSC as of Q1 2016.

  • Akanthos Capital Management reported no remaining Fibrocell Science Inc. position as of Q1 2016 after selling out during the quarter.
  • Akanthos Capital Management sold 3,767 Fibrocell Science Inc. shares in Q1 2016, an estimated $257K.
  • Akanthos Capital Management first reported a position in Fibrocell Science Inc. in Q2 2013 and held it in 3 quarters.
  • Akanthos Capital Management's Fibrocell Science Inc. position peaked at $1.28M in Q2 2013.
  • 52 funds tracked by Wall St. Rank held Fibrocell Science Inc. as of Q1 2016.

Based on Akanthos Capital Management's 13F filing for Q1 2016, filed 11 May 2016.